Page 2 - Robertm Plenge News Today

StockNews.com upgraded shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday. Other equities research analysts have also issued reports about the stock. UBS Group reiterated a neutral rating and issued a $60.00 price target (down from $70.00) on shares of Bristol-Myers […]

William Blair lowered shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Friday, MarketBeat reports. William Blair also issued estimates for Bristol-Myers Squibb’s Q3 2023 earnings at $1.81 EPS, Q4 2023 earnings at $1.78 EPS, FY2023 earnings at $7.39 […]

Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price lowered by Barclays from $60.00 to $51.00 in a research note published on Friday morning, Benzinga reports. Barclays currently has an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. Truist Financial restated a buy rating […]

Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price cut by Morgan Stanley from $56.00 to $50.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have an underweight rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Bank of America lowered their […]

Aviance Capital Partners LLC boosted its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 84,227 shares of the biopharmaceutical company’s stock after purchasing an additional 5,366 shares during the quarter. Bristol-Myers […]

WealthTrust Asset Management LLC lessened its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 21.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,239 shares of the biopharmaceutical company’s stock after selling 3,632 shares during the quarter. WealthTrust Asset Management LLC’s […]

Iowa State Bank reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,880 shares of the biopharmaceutical company’s stock after selling 1,087 shares during the quarter. Iowa State Bank’s holdings […]

Princeton Global Asset Management LLC trimmed its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 14.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,841 shares of the biopharmaceutical company’s stock after selling 6,850 shares during the quarter. […]

Los Angeles Capital Management LLC lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 31.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,522,188 shares of the biopharmaceutical company’s stock after selling 696,054 shares during the quarter. Los Angeles Capital […]

JNBA Financial Advisors reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,125 shares of the biopharmaceutical company’s stock after selling 845 shares during the […]